GlassScriptPhysician profile
Angela Hignite
NPI 1356609895
$643.98
in general payments reported to CMS, 2019-2025
13 companies · $74.24 in 2025
The $74.24 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.68 · 2020: $81.90 · 2022: $22.37 · 2023: $41.39 · 2024: $399 · 2025: $74.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $217.08 | 2024 | Spy-Phi System |
| Gilead Sciences, INC. | $120.36 | 2024 | Epclusa |
| Organogenesis INC. | $81.90 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.95 | 2024-2025 | Caplyta |
| Corcept Therapeutics | $39.84 | 2024-2025 | Korlym |
| Glaxosmithkline, LLC. | $24.28 | 2019-2023 | Trelegy Ellipta |
| Abbott Laboratories | $22.37 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.37 | 2024 | Hetlioz, Fanapt |
| Amgen INC. | $15.38 | 2023 | Otezla, Repatha |
| Abbvie INC. | $14.54 | 2025 | |
| Exact Sciences Corporation | $14.50 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $13.82 | 2019 | |
| Organon LLC | $12.59 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Hignite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.